Browsing by Author Kennedy Cruickshank, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2009Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trialPatel, Anushka; Beulens, Joline W. J.; Grobbee, Diederick; Hughes, Alun D; Kennedy Cruickshank, J; Lu, Juming; McG Thom, S; Stanton, A; Stolk, Ronald P.; Vingerling, Johannes R.; The George Institute for International HealthEffects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial, Diabetologia: clinical and experimental diabetes and metabolism, vol.52, 10,pp 2027-2036
2007Rationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitusPatel, Anushka; Grobbee, Diederick E.; Hughes, Alun. D; Juming, Lu; Kennedy Cruickshank, J; Stanton, Alice; Stolk, Ronald P.; Thom, Simon. A. McG.; Vingerling, Johannes R.; The George Institute for International HealthRationale and design of the AdRem study: Evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus, Contemporary Clinical Trials, vol.28,(1),2007,pp 6-17
2008Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) studyPatel, Anushka; Grobbee, Diederick; Hughes, Alun D; Kennedy Cruickshank, J; Lu, Juming; Stanton, Alice V; Stolk, Ronald P.; Thom, Simon. A. McG.; van Schooneveld, Mary J; Vingerling, Johannes R.; The George Institute for Global HealthRetinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) study, Diabetes Care, vol.31, 4, 2008,pp 708-713